Page last updated: 2024-11-05

zonisamide and Libman-Sacks Disease

zonisamide has been researched along with Libman-Sacks Disease in 2 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
" Dosage was gradually increased up to 200 to 500 mg/day, and the seizures were controlled satisfactorily."1.32Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis. ( Fukuda, F; Ijiri, Y; Inoue, T; Kobayashi, T; Shibahara, N; Suzuki, K; Takenaka, H; Tanaka, K, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ijiri, Y1
Inoue, T1
Fukuda, F1
Suzuki, K1
Kobayashi, T1
Shibahara, N1
Takenaka, H1
Tanaka, K1
Mutoh, K1
Hidaka, Y1
Hirose, Y1
Kimura, M1

Other Studies

2 other studies available for zonisamide and Libman-Sacks Disease

ArticleYear
Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis.
    Epilepsia, 2004, Volume: 45, Issue:8

    Topics: Adult; Anticonvulsants; Anuria; Comorbidity; Drug Administration Schedule; Female; Hemodialysis Solu

2004
Possible induction of systemic lupus erythematosus by zonisamide.
    Pediatric neurology, 2001, Volume: 25, Issue:4

    Topics: Antibodies, Antinuclear; Anticonvulsants; Child, Preschool; Epilepsy, Tonic-Clonic; Humans; Isoxazol

2001